DJE Kapital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.7M Sell
270,161
-346,115
-56% -$30.3M 0.48% 48
2026
Q1
$52.3M Buy
616,276
+549,405
+822% +$49M 1.16% 25
2025
Q4
$5.34M Sell
66,871
-142,723
-68% -$11.2M 0.15% 67
2025
Q3
$18.8M Hold
209,594
0.46% 47
2025
Q2
$18.8M Sell
209,594
-252,374
-55% -$23M 0.46% 47
2025
Q1
$43.3M Sell
461,968
-655,409
-59% -$58.7M 1.28% 26
2024
Q4
$102M Buy
+1,117,377
New +$107M 2.38% 14

Other funds holding CL

DJE Kapital's CL Position: Q2 2026 in Review

DJE Kapital reduced its Colgate-Palmolive (CL) stake by 56% in Q2 2026, selling an estimated $30.3M and leaving 270,161 shares worth $25.7M. The position accounts for 0.48% of the portfolio, ranked #48.

DJE Kapital first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $102M in Q4 2024. 2,017 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • DJE Kapital held 270,161 shares of Colgate-Palmolive worth $25.7M as of Q2 2026.
  • DJE Kapital sold 346,115 Colgate-Palmolive shares in Q2 2026, an estimated $30.3M.
  • Colgate-Palmolive made up 0.48% of DJE Kapital's portfolio in Q2 2026, its #48 holding.
  • DJE Kapital first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • DJE Kapital's Colgate-Palmolive position peaked at $102M in Q4 2024.
  • 2,017 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on DJE Kapital's 13F filing for Q2 2026, filed 4 Aug 2026.